keyword
https://read.qxmd.com/read/38635368/high-remission-rates-and-transition-to-allogeneic-transplant-in-older-patients-with-newly-diagnosed-flt-3-mutated-acute-myelogenous-leukemia-with-midostaurin-plus-intensive-chemotherapy
#1
JOURNAL ARTICLE
Jose Tinajero, Dat Ngo, Jianying Zhang, Ni-Chun Tsai, Ahmed Aribi, Ibrahim Aldoss, Vaibhav Agrawal, Shukaib Arslan, Idoroenyi Amanam, Hoda Pourhassan, Karamjeet Sandhu, Monzr Al-Malki, Vinod Pullarkat, Pamela Becker, Ryotaro Nakamura, Anthony Stein, Guido Marcucci, Andrew Artz, Paul Koller, Amandeep Salhotra
No abstract text is available yet for this article.
April 18, 2024: Leukemia & Lymphoma
https://read.qxmd.com/read/38506376/effect-of-nonsteroidal-anti-inflammatory-drugs-aspirin-and-naproxen-on-inflammation-associated-proteomic-profiles-in-mouse-plasma-and-prostate-during-tmprss2-erg-fusion-driven-prostate-carcinogenesis
#2
JOURNAL ARTICLE
Ram Raj Prasad, Neha Mishra, Rama Kant, Jennifer T Fox, Robert H Shoemaker, Chapla Agarwal, Komal Raina, Rajesh Agarwal
Recent preclinical studies have shown that the intake of nonsteroidal anti-inflammatory drugs (NSAIDs) aspirin and naproxen could be an effective intervention strategy against TMPRSS2-ERG fusion-driven prostate tumorigenesis. Herein, as a follow-up mechanistic study, employing TMPRSS2-ERG (fusion) positive tumors and plasma from TMPRSS2-ERG. Ptenflox/flox mice, we profiled the stage specific proteomic changes (focused on inflammatory circulating and prostate tissue/tumor-specific cytokines, chemokines, and growth factors/growth signaling-associated molecules) that contribute to prostate cancer (PCa) growth and progression in the TMPRSS2-ERG fusion-driven mouse model of tumorigenesis...
March 20, 2024: Molecular Carcinogenesis
https://read.qxmd.com/read/38270613/midostaurin-drug-interaction-profile-a-comprehensive-assessment-of-cyp3a-cyp2b6-and-cyp2c8-drug-substrates-and-oral-contraceptives-in-healthy-participants
#3
JOURNAL ARTICLE
Romain Sechaud, Helen Gu, Gholamreza Rahmanzadeh, Amanda Taylor, Ovidiu Chiparus, Gopal Krishna Sharma, Astrid Breitschaft, Hans D Menssen
PURPOSE: Midostaurin, approved for treating FLT-3-mutated acute myeloid leukemia and advanced systemic mastocytosis, is metabolized by cytochrome P450 (CYP) 3A4 to two major metabolites, and may inhibit and/or induce CYP3A, CYP2B6, and CYP2C8. Two studies investigated the impact of midostaurin on CYP substrate drugs and oral contraceptives in healthy participants. METHODS: Using sentinel dosing for participants' safety, the effects of midostaurin at steady state following 25-day (Study 1) or 24-day (Study 2) dosing with 50 mg twice daily were evaluated on CYP substrates, midazolam (CYP3A4), bupropion (CYP2B6), and pioglitazone (CYP2C8) in Study 1; and monophasic oral contraceptives (containing ethinylestradiol [EES] and levonorgestrel [LVG]) in Study 2...
January 25, 2024: Cancer Chemotherapy and Pharmacology
https://read.qxmd.com/read/38164785/treatment-of-relapsed-or-refractory-flt-3-acute-myelogenous-leukemia-with-a-triplet-regimen-of-hypomethylating-agent-venetoclax-and-gilteritinib
#4
JOURNAL ARTICLE
Dat Ngo, Jose Tinajero, Shanpeng Li, Joycelynne Palmer, Hoda Pourhassan, Ahmed Aribi, Ryotaro Nakamura, Anthony Stein, Guido Marcucci, Amandeep Salhotra, Karamjeet Sandhu, Vinod Pullarkat, Brian Ball, Paul Koller
Relapsed or refractory (R/R) acute myeloid leukemia (AML) with FMS-like tyrosine kinase 3 (FLT3) mutations remains a difficult and hard to treat entity. Gilteritinib is a potent oral FLT-3 inhibitor that improves overall survival in R/R AML, but studies are limited in combining gilteritinib with a hypomethylating agent and venetoclax treatment backbone (HMA-VEN-GILT). Here we report our experience with HMA-VEN-GILT for 22 R/R FLT3 AML patients. HMA-VEN-GILT yielded an ORR of 77.3% (17/22), CR 4.5% (1/22), CRi 13...
March 2024: Leukemia & Lymphoma
https://read.qxmd.com/read/38060271/flt-3-ing-about-the-search-for-the-best-inhibitor
#5
EDITORIAL
Richard M Stone
No abstract text is available yet for this article.
December 7, 2023: Blood
https://read.qxmd.com/read/38025384/effects-of-repeated-binge-intake-of-the-pyrovalerone-cathinone-derivative-3-4-methylenedioxypyrovalerone-on-prefrontal-cytokine-levels-in-rats-a-preliminary-study
#6
JOURNAL ARTICLE
Erin K Nagy, Jonna M Leyrer-Jackson, Lauren E Hood, Amanda M Acuña, M Foster Olive
Drugs of abuse activate neuroimmune signaling in addiction-related regions of the brain, including the prefrontal cortex (PFC) which mediates executive control, attention, and behavioral inhibition. Traditional psychostimulants including methamphetamine and cocaine are known to induce PFC inflammation, yet the effects of synthetic cathinone derivatives are largely unexplored. In this study, we examined the ability of repeated binge-like intake of the pyrovalerone cathinone derivative 3,4-methylenedioxypyrovalerone (MDPV) to alter cytokine profiles in the PFC...
2023: Frontiers in Behavioral Neuroscience
https://read.qxmd.com/read/38007372/soho-state-of-the-art-updates-and-next-questions-understanding-and-overcoming-venetoclax-resistance-in-hematologic-malignancies
#7
REVIEW
Mark Forsberg, Marina Konopleva
The discovery of Venetoclax (VEN) has transformed the therapeutic landscape of acute myeloid leukemia (AML) and chronic lymphocytic leukemia (CLL). However, the response is heterogeneous with 10% to 50% of newly diagnosed AML patients not responding to hypomethylating agent (HMA) and VEN. Furthermore, up to 40% of responding patients relapse shortly. This review discusses the mechanism of action of Venetoclax and the major mechanisms of inherent and acquired resistance to VEN. VEN is highly specific to BCL-2 binding, as such other antiapoptotic proteins in BCL-2 family induce resistance...
January 2024: Clinical Lymphoma, Myeloma & Leukemia
https://read.qxmd.com/read/37981104/interleukin-1-receptor-accessory-protein-il-1rap-a-magic-bullet-candidate-for-immunotherapy-of-human-malignancies
#8
REVIEW
Ali Zarezadeh Mehrabadi, Faezeh Shahba, Hossein Khorramdelazad, Nazanin Aghamohammadi, Milad Karimi, Kowsar Bagherzadeh, Majid Khoshmirsafa, Ramin Massoumi, Reza Falak
IL-1, plays a role in some pathological inflammatory conditions. This pro-inflammatory cytokine also has a crucial role in tumorigenesis and immune responses in the tumor microenvironment (TME). IL-1 receptor accessory protein (IL-1RAP), combined with IL-1 receptor-1, provides a functional complex for binding and signaling. In addition to the direct role of IL-1, some studies demonstrated that IL1-RAP has essential roles in the progression, angiogenesis, and metastasis of solid tumors such as gastrointestinal tumors, lung carcinoma, glioma, breast and cervical cancers...
January 2024: Critical Reviews in Oncology/hematology
https://read.qxmd.com/read/37857311/asteriquinones-from-aspergillus-sp-gzwmjz-258-and-their-derivatives
#9
JOURNAL ARTICLE
Liping Wang, Wenwen He, Xiaoyang Wang, Gang Li, Dongyang Wang, Yanchao Xu, Weiming Zhu
A new asteriquinone, ochrindole F ( 1 ), and five previously reported analogues ( 2 - 6 ) were isolated from the culture of the fungus Aspergillus sp. GZWMJZ-258, an endophyte of Garcinia multiflora . The structure of compound 1 was determined by a spectroscopic analysis. Furthermore, eight new derivatives ( 7 - 14 ) were synthesized from major metabolites 2 and 3 . These compounds showed selective antiproliferative activity against the human acute myeloid leukemia (AML) cell line MV4-11, among which compound 12 showed the strongest activity with an IC50 value of 0...
October 19, 2023: Journal of Natural Products
https://read.qxmd.com/read/37817968/involvement-value-of-flt-3-c-myc-stat3-p27-and-hotair-gene-expression-in-acute-myeloid-leukemia-patients-a-molecular-perspective-to-a-novel-leukemogenesis-mechanism
#10
JOURNAL ARTICLE
Naser Shagerdi Esmaeli, Shahin Asadi, Davood Bashash, Sina Salari, Mohsen Hamidpour
Background: The identification of long non-coding RNAs (lncRNAs) in the pathogenesis of acute myeloid leukemia (AML) has marked a new era in the molecular understating of the disease. This study investigated the correlation between the changes in the expression of lncRNAs, including HOTAIR, PVT-1, and CRNDE, and the alteration in the expression profile of FLT-3, c-Myc, STAT3, STAT5, and p27 in AML patients. Materials and Methods: Blood samples were collected from forty-one newly diagnosed AML patients and ten healthy individuals to evaluate the expression levels of the study genes using qRT-PCR analysis...
July 1, 2023: International Journal of Hematology-oncology and Stem Cell Research
https://read.qxmd.com/read/37603683/improved-post-transplant-outcomes-in-recent-years-for-aml-patients-with-flt3-itd-and-wild-type-npm1-a-report-from-the-ebmt-acute-leukemia-working-party
#11
JOURNAL ARTICLE
Ali Bazarbachi, Myriam Labopin, Tobias Gedde-Dahl, Peter Remenyi, Edouard Forcade, Nicolaus Kröger, Gerard Socié, Charles Craddock, Jean Henri Bourhis, Jurjen Versluis, Ibrahim Yakoub-Agha, Urpu Salmenniemi, Jean El-Cheikh, Gesine Bug, Jordi Esteve, Arnon Nagler, Fabio Ciceri, Mohamad Mohty
PURPOSE: Allogeneic hematopoietic cell transplantation (allo-HCT) is recommended in first complete remission (CR1) in acute myeloid leukemia (AML) patients harboring FLT3 internal tandem duplication (FLT3-ITD). We assessed changes over time in transplant characteristics and outcomes in AML patients aged 60 years and younger with a FLT3 ITD. EXPERIMENTAL DESIGN: We identified 1827 adult AML patients (median age 49 years, range 18-60) with FLT3 ITD and intermediate karyotype, allografted between 2012 and 2021 in CR1...
August 21, 2023: Clinical Cancer Research
https://read.qxmd.com/read/37575212/outcomes-of-patients-with-flt3-positive-acute-myeloid-leukaemia-an-experience-from-a-tertiary-care-hospital-in-karachi-pakistan
#12
JOURNAL ARTICLE
Maria Zulfiqar, Natasha Ali, Usman Shaikh, Hamzah Jehanzeb, Salman Arif, Zurrya Fasih Khan, Nabiha Saeed, Zeeshan Ansar
INTRODUCTION: Molecular genetic abnormalities in acute myeloid leukaemia (AML) are essential for disease diagnosis and determining prognosis and clinical course. Mutations in FLT3 and nucleophosmin (NPM) genes are the most frequent genetic abnormalities, which are also known to impact disease outcomes. FLT3 mutations have been identified in approximately 30% of de novo AML patients and are associated with poor prognoses. This study aimed to determine the response to induction chemotherapy, overall survival (OS) and relapse rate (RR) in patients with FLT3-positive AML...
2023: Journal of cancer & allied specialties
https://read.qxmd.com/read/37554292/increased-intraocular-inflammation-in-retinal-vein-occlusion-is-independent-of-circulating-immune-mediators-and-is-involved-in-retinal-oedema
#13
JOURNAL ARTICLE
Yufan Zhou, Jinyan Qi, Hengwei Liu, Shengnan Liang, Tingting Guo, Juan Chen, Wei Pan, Huanhuan Tan, Jie Wang, Heping Xu, Zhongping Chen
We aim to understand the link between systemic and intraocular levels of inflammatory mediators in treatment-naïve retinal vein occlusion (RVO) patients, and the relationship between inflammatory mediators and retinal pathologies. Twenty inflammatory mediators were measured in this study, including IL-17E, Flt-3 L, IL-3, IL-8, IL-33, MIP-3β, MIP-1α, GRO β, PD-L1, CD40L, IFN-β, G-CSF, Granzyme B, TRAIL, EGF, PDGF-AA, PDGF-AB/BB, TGF-α, VEGF, and FGFβ. RVO patients had significantly higher levels of Flt-3 L, IL-8, MIP-3β, GROβ, and VEGF, but lower levels of EGF in the aqueous humor than cataract controls...
2023: Frontiers in Neuroscience
https://read.qxmd.com/read/37531875/isolation-and-culture-of-chicken-bone-marrow-derived-cd34-hematopoietic-stem-and-progenitor-cells-and-induced-differentiation-to-myeloid-cells
#14
JOURNAL ARTICLE
Shuhai He, Jing Guo, Dan Rao, Jianguo Dong, Gege Wei, Xu Wang, Shouxiao Huang, Xianguo Yi
Hematopoietic stem and progenitor cell (HSPC) research will help elucidate the pathogenesis of hematologic diseases. The present study aimed to establish an isolation method and culture system for chicken bone marrow (BM)-derived HSPCs and test their proliferation and differentiation abilities. Mononuclear cells were collected from chicken BM, and CD34+ HSPCs were isolated. Then, the cells were cultured in media with different cytokine compositions, and the growth status, cell phenotype, and morphological appearance of the cells were analyzed at different time points...
July 28, 2023: Tissue & Cell
https://read.qxmd.com/read/37428863/targeting-conditioned-media-dependencies-and-flt-3-in-chronic-lymphocytic-leukemia
#15
JOURNAL ARTICLE
Salma Parvin, Aditi Aryal, Shanye Yin, Geoffrey G Fell, Matthew S Davids, Catherine J Wu, Anthony Letai
The importance of the stromal microenvironment in chronic lymphocytic leukemia (CLL) pathogenesis and drug resistance is well established. Despite recent advances in CLL therapy, identifying novel ways to disrupt interactions between CLL and its microenvironment may identify new combination partners for the drugs currently in use. To understand the role of microenvironmental factors on primary CLL cells, we took advantage of an observation that conditioned media (CM) collected from stroma was protective of CLL cells from spontaneous cell death ex vivo...
July 10, 2023: Blood Advances
https://read.qxmd.com/read/37271215/a-new-cyclin-dependent-kinase-9-inhibitor-a09-003-induces-apoptosis-in-acute-myeloid-leukemia-cells-with-reduction-of-myeloid-cell-leukemia-sequence-1-protein
#16
JOURNAL ARTICLE
Kyoung Mi Sim, So Young Kim, Supyong Hwang, Sojung Park, Bo Ra Lee, Kyyoub Nam, SeakHee Oh, Inki Kim
Acute myeloid leukemia (AML) is the most common type of hematological disease in adults, and has a very poor outcome [1]. Based on its wide range of efficacy in AML models, a small-molecule inhibitor of the anti-apoptotic protein BCL-2, venetoclax (ABT-199/GDC-0199), was developed for clinical trials. However, venetoclax showed limited monotherapy activity [2]. The overexpression of myeloid cell leukemia sequence-1 protein (Mcl-1)-due to mutations in Fms-like tyrosine kinase 3 internal tandem duplication (FLT-3 ITD)-was considered to be the main reason for low efficacy of venetoclax in clinical trials [3-5]...
June 2, 2023: Chemico-biological Interactions
https://read.qxmd.com/read/37129774/oral-azacitidine-for-maintenance-treatment-of-acute-myeloid-leukaemia-after-induction-therapy-an-evidence-review-group-perspective-of-a-nice-single-technology-appraisal
#17
REVIEW
Willem Witlox, Sabine Grimm, Jeremy Howick, Nigel Armstrong, Charlotte Ahmadu, Kevin McDermott, Thomas Otten, Caro Noake, Robert Wolff, Manuela Joore
The National Institute for Health and Care Excellence (NICE) invited the manufacturer (Celgene) of oral azacitidine (ONUREG), as part of the Single Technology Appraisal (STA) process, to submit evidence for the clinical effectiveness and cost-effectiveness of oral azacitidine for maintenance treatment of acute myeloid leukaemia (AML) after induction therapy compared with watch-and-wait plus best supportive care (BSC) and midostaurin. Kleijnen Systematic Reviews Ltd, in collaboration with Maastricht University Medical Centre+, was commissioned to act as the independent Evidence Review Group (ERG)...
May 2, 2023: PharmacoEconomics
https://read.qxmd.com/read/37100025/efficacy-and-tolerability-of-isocitrate-dehydrogenase-inhibitors-in-patients-with-acute-myeloid-leukemia-a-systematic-review-of-clinical-trials
#18
REVIEW
Wajeeha Aiman, Muhammad Ashar Ali, Muhammad Abdul Basit, Zainab Omar, Muhammad Suleman, Muhammad Hassan, Taimoor Jamil, Muhammad Saad Anwar, Zubair Shafique, Gurneel Dhanesar, Muhammad Salman Faisal, Michael J Akerman, Michael Maroules, Faiz Anwer
BACKGROUND: Acute myeloid leukemia (AML) is a hematological malignancy due to anomalous differentiation and proliferation of hematopoietic stem cells with myeloid blast buildup. Induction chemotherapy is considered the first line of treatment in most patients with AML. However, targeted therapy in the form of FLT-3, IDH, BCL-2, and immune checkpoint inhibitors, can be considered as the first line depending on their molecular profile, resistance to chemotherapy, comorbidities, etc. This review aims to assess the tolerability and efficacy of isocitrate dehydrogenase (IDH) inhibitors in AML...
April 14, 2023: Leukemia Research
https://read.qxmd.com/read/36852801/application-and-sars-of-pyrazolo-1-5-a-pyrimidine-as-antitumor-agents-scaffold
#19
JOURNAL ARTICLE
Yadong Zhang, Di Wen, Jiwei Shen, Lu Tian, Yan Zhu, Jifang Zhang, Leyan Zhao, Shi Ding, Ju Liu, Ye Chen
Pyrazolo[1,5-a]pyrimidines are fused heterocycles that have spawned many biologically active antitumor drugs and are important privileged structures for drug development. Pyrazolo[1,5-a]pyrimidine derivatives have played an important role in the development of antitumor agents due to their structural diversity and good kinase inhibitory activity. In addition to their applications in traditional drug targets such as B-Raf, KDR, Lck, and Src kinase, some small molecule drugs with excellent activity against other kinases (Aurora, Trk, PI3K-γ, FLT-3, C-Met kinases, STING, TRPC) have emerged in recent years...
February 28, 2023: Current Topics in Medicinal Chemistry
https://read.qxmd.com/read/36834006/how-can-digital-financial-inclusion-promote-high-quality-agricultural-development-the-multiple-mediation-model-research
#20
JOURNAL ARTICLE
Hua Zhang, Ying Li, Hanxiaoxue Sun, Xiaohui Wang
In order to balance the relationship between economics, society and environment, the Chinese government has stated that China's economy should shift from high-speed growth to high-quality development. Since agriculture is the foundation of the national economy, high-quality development of agriculture plays significant roles in the achievement of food security, social stability and environmental sustainability in China. In practice, the expansion of digital financial inclusion (DFI) seems to provide valuable opportunities for the development of high-quality agriculture...
February 14, 2023: International Journal of Environmental Research and Public Health
keyword
keyword
94343
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.